Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Winnergy Medical PCLBKK:WINMED +1.14%59 ROE % is 2.01% as of Mar. 2026, which is 81% below its 10-year median of 10.40. GuruFocus rates BKK:WINMED with a GF Score™ of 59/100 and a GF Value™ of ฿1.86 (Possible Value Trap). The stock has 11 warning signs investors should review. Among 114 Medical Distribution companies, Winnergy Medical PCL ranks worse than 71.93% on this metric.
Winnergy Medical PCL (BKK:WINMED) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Winnergy Medical PCL's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Winnergy Medical PCL ROE % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Winnergy Medical PCL's ROE % distribution charts can be found below:
* The bar in red indicates where Winnergy Medical PCL's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Winnergy Medical PCL (BKK:WINMED) has a ROE % of 2.01% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Winnergy Medical PCL and its competitors. This is 81% below median its historical median of 10.40. According to the industry distribution chart, Winnergy Medical PCL ranks #82 out of 114 companies in the Medical Distribution industry, placing it in the top 71.9%.
Is Winnergy Medical PCL's ROE % too high?
Winnergy Medical PCL's current ROE % of 2.01% is 81% below median its 10-year median of 10.40. The Medical Distribution industry median ROE % is 7.13. Winnergy Medical PCL's value of 2.01% is 71.8% below this industry median. Based on the distribution chart, Winnergy Medical PCL ranks #82 out of 114 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Winnergy Medical PCL has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Winnergy Medical PCL's ROE % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Winnergy Medical PCL ranks #82 out of 114 companies for ROE %. This places Winnergy Medical PCL in the lower half of its industry. The industry median ROE % is 7.13. Winnergy Medical PCL's value of 2.01% is 71.8% below this benchmark. While the company's 10-year median is 10.40 vs. the industry median of 7.13, Winnergy Medical PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Medical Distribution company?
The median ROE % among Medical Distribution companies is 7.13, based on 114 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Winnergy Medical PCL's current ROE % of 2.01% is 71.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Winnergy Medical PCL and its competitors. For the Medical Distribution industry, the median ROE % is 7.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Winnergy Medical PCL's current ROE % is 2.01%, which is 81% below median its own 10-year median of 10.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Winnergy Medical PCL stock overvalued right now?
Based on GuruFocus' analysis, Winnergy Medical PCL (BKK:WINMED) is currently considered Possible Value Trap. The stock's GF Value™ is ฿1.86, compared to a current price of ฿0.89 — trading 52.2% below its estimated fair value. The current ROE % is 2.01%, which is 81% below median its 10-year median of 10.40 and 71.8% below the Medical Distribution industry median of 7.13. Winnergy Medical PCL's overall GF Score™ is 59/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Winnergy Medical PCL (BKK:WINMED), the current ROE % is 2.01% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Winnergy Medical PCL (BKK:WINMED) Overvalued in 2026?
Based on GuruFocus' analysis, Winnergy Medical PCL stock appears to be undervalued.
The current stock price of ฿0.89 is trading 52.2% below its estimated GF Value™ of ฿1.86.
GuruFocus considers Winnergy Medical PCL to be Possible Value Trap.
Key valuation signals for BKK:WINMED:
ROE %: 2.01% (81% below median its 10-year median of 10.40)
GF Value™: ฿1.86 vs. price of ฿0.89 (52.2% below fair value)
Industry Position: 71.8% below the Medical Distribution median (#82 of 114)
No single metric tells the full story. See the BKK:WINMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Winnergy Medical PCL is engaged in the distribution of medical and diagnostics equipment. Its businesses include the distribution of medical devices, chemicals, and medical equipment and technology. The company operates in the geographic area of Thailand.
59GF Score
Get the complete analysis for BKK:WINMED
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:WINMED has been successfully added to your 
